Making a health case for reparations in Boston
Presented jointly with the FXB Center for Health and Human Rights As the national conversation on reparations heats up, Boston has launched a task force to d…
Presented jointly with the FXB Center for Health and Human Rights As the national conversation on reparations heats up, Boston has launched a task force to d…
BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it concentrates its resources on an anticipated launch of its pivotal…
Shoulder popping, also known as crepitus, has several possible causes. Find out why you might experience pain, when to contact a doctor, and how to…
Becton Dickinson raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical equipment…
A global review of three decades of health data has revealed huge health differences in men and women that begin in adolescence and grow throughout…
Register for ATA Nexus 2024 to engage with decision-makers and hear from industry leaders. Discounts are available for early birds and qualified members.
Nguyen et al. investigate mechanisms of acquired chemotherapy resistance in pancreatic ductal adenocarcinoma (PDAC). By identifying the PRMT1-MAFF/BACH1 axis as a key mechanism of response to…
Novartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1 billion, the Swiss drug manufacturer said on Thursday.
Novartis already produces the leading drug in the radiopharmaceutical field. Now, it is devoting even more attention to these cancer treatments with a new acquisition.Â
Novartis will pay $1 billion upfront to acquire radiopharmaceutical startup Mariana Oncology, just eight months after the preclinical biotech company disclosed a $175 million Series…
Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07) Prepares for launches of RSV vaccine…